San Jose startup gets $53M to turn injectable drugs into pills
Thursday, 8 February 2018 () Rani Therapeutics Inc. has raised $53 million in new funding as it prepares for human clinical testing of its pills that are designed to take the place of injectable drugs. The San Jose-based company led by entrepreneur and venture capitalist Mir Imran said that the new round brings its total funding to date to $142 million. New investors in the round include GeneScience Pharmaceuticals Co. Ltd., a major biopharmaceuticals company from China; global biotech Shire plc (NASDAQL:SHPG); Bossa Ventures,…